UMN Pharma completes $0.9 million Series A round (second tranche), with participation of 2 venture capital firms.

UMN Pharma Inc. raised $ 0.9 million in Series A round (second tranche) from 2 venture capitals, Pacific Rim Ventures and ASTEC.
This financing was provided by having achieved the second milestone set last November.